Seegene analysis of about 60,000 test results found STI pathogens [...]

The founder of the International Ovarian Tumor Analysis collaboration has [...]

ReproNovo has dosed the first participant in a European Phase [...]

Gesynta Pharma has randomised half of the planned patients in [...]

Medicus Pharma has submitted an investigational new drug application in [...]

Ultrahuman and Click Therapeutics have entered a partnership to develop [...]

Women’s health remains underfunded, underdiagnosed and undervalued — but a [...]

Cook MyoSite and Veristat have reached a key enrolment milestone [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

Gesynta Pharma has announced the second closing of its Series [...]